In murine models, inactivation of the tumor suppressor gene STK11/LKB1 led to significant increases in tumor-promoting cytokines and neutrophil activity; treatment of mice with an IL-6 antibody decreased the degree of tumor-associated neutrophils and improved survival as compared to control mice (64). This evidence concerns the gene IL6 and neoplasm.